UNSPSC 51402403: Azacyclonol hydrochloride

This classification denotes an anxiolytic with the molecular formula C18H21NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4BXX0XNP9R, chemically known as 4-piperidinemethanol, alpha,alpha-diphenyl-, hydrochloride but more generally known as azacyclonol hydrochloride, which bears US NIH Compound Identifier 15722. European Medicines Agency schedules Azacyclonol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00635MIG.

Most nations, for tariff and trade purposes, schedule azacyclonol hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, AZACYCLONOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Azacyclonol hydrochloride bears US NLM identifiers UMLS ID C0959907 and NCI Concept Code C76503. SMILES: C1CCC(CC1)C(C2CCCCC2)(C3CCNCC3)O.CL.

UNSPSC 51402403 Azacyclonol hydrochloride is a Commodity code that covers pharmaceutical products, but recent state and local solicitations tagged under this code do not align with azacyclonol hydrochloride specifically. Instead, the opportunities posted involve naloxone (opioid-antagonist medication), generic multi-source pharmaceuticals and over-the-counter products, and direct-to-manufacturer prescription programs. The issuing bodies span state health and human services agencies, county health departments, and multistate cooperative purchasing alliances. Seminole County, Florida, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the repeat buyers in the recent record, with MMCAP administering cooperative purchasing across multiple states including Oregon and participating in group purchasing across state and local government facilities.

Recent opportunities show activity primarily in Florida and Texas, with cooperative purchasing reach extending to multiple states through MMCAP. Seminole County released IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023 (note: source date inconsistency). The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling early-stage procurement planning rather than active competitive solicitation. MMCAP released RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across state and local government facilities, with proposals due March 26, 2026 and contract effectiveness targeted for July 1, 2026. The code shows limited recent activity directly aligned with azacyclonol hydrochloride; procurement under the nominal code appears to focus on broader pharmaceutical supply categories and alternate opioid-related medications.